- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Indrayani Biotech Limited has announced a delay in submitting its standalone and consolidated financial results for the quarter ended 31st December, 2025. The company stated that the audit process for its financials is still ongoing, which is the reason for this deferral. The results will be declared once the audit is finalized. Consequently, the trading window for dealing in the company's securities remains closed for all designated persons until 48 hours after the financial results are declared.